A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
Recruiting now · Phase 1
Conditions studied: Parkinson Disease
In brief
The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants with Parkinson's disease.
Key facts
- Study ID
- NCT07513441
- Run by
- H. Lundbeck A/S
- People needed
- 10
- Starts
- 2026-05-26
- Expected to finish
- 2027-05-31
- Last updated by the study team
- 2026-08-10
Who can join
Age: 35 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Beijing TiantanHospital, CapitalMedical University — Beijing, Beijing Municipality, China (enrolling)
- Xuanwu Hospital Capital Medical University — Beijing, Beijing Municipality, China (enrolling)
- Fudan University - Huashan Hospital - Institute of Urology — Shanghai Shi, Shanghai Municipality, China (enrolling)
- West China Hospital, Sichuan University — Chengdu, Sichuan, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.